One of the following is not true about nesiritide ?
**Core Concept**
Nesiritide is a recombinant human B-type natriuretic peptide (BNP) analog used in the treatment of acute decompensated heart failure. It works by promoting vasodilation, natriuresis, and diuresis, thereby reducing pulmonary capillary wedge pressure and systemic vascular resistance.
**Why the Correct Answer is Right**
Nesiritide acts by binding to the guanylate cyclase receptor on the surface of vascular smooth muscle cells, which leads to increased levels of cyclic guanosine monophosphate (cGMP). cGMP then activates protein kinase G, causing vasodilation and reducing blood pressure. Additionally, nesiritide inhibits the release of atrial natriuretic peptide (ANP) and stimulates the release of renin, which contributes to its natriuretic and diuretic effects.
**Why Each Wrong Option is Incorrect**
**Option A:** While nesiritide is used in acute decompensated heart failure, it is not indicated for the treatment of hypertension. Nesiritide can actually cause hypotension as a side effect, making it a poor choice for hypertension management.
**Option B:** This statement is true about nesiritide. It does have a role in reducing pulmonary capillary wedge pressure and systemic vascular resistance.
**Option C:** Nesiritide does have a role in promoting natriuresis and diuresis, which is beneficial in the treatment of heart failure.
**Option D:** This statement is not true. While nesiritide is a vasodilator, its primary mechanism of action is not through the inhibition of the renin-angiotensin-aldosterone system (RAAS).
**Clinical Pearl / High-Yield Fact**
Nesiritide is a BNP analog, but it is not a substitute for diuretics in heart failure management. Its use should be limited to patients who are volume overloaded and have persistent symptoms despite diuretic therapy.
**Correct Answer: A. Nesiritide is not indicated for the treatment of hypertension.**